Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Celgene
>
52-week low; not a good sign
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6075102"]Damn you are dumb. Ask AbbVie if they sell any Humira? Oh, they do at the clip of about $24 billion a year. Go read their 10k. Oh, yes - they rebate about $6.75 billion a year. </p><p><br /></p><p>You see, in the I&I market, rebates are the cost of entry. If you don't rebate, you don't sell.</p><p><br /></p><p>In the cancer world, end users simply use the best product because the best products are mandated by society and payer guidelines. You don't actually even need reps. Rev sells itself. Reps can't see docs anyway.</p><p><br /></p><p>You sound like the arrogant imbeciles that have blocked I&I from contracting all along. Had you just given 1.25% of R to sweeten the deals back in 2015, Otezla would have a 90% share in the pre-biologic market by now, but your arrogance killed it. Go have a beer with Scott, Jackie and Bob and you'll see.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6075102"]Damn you are dumb. Ask AbbVie if they sell any Humira? Oh, they do at the clip of about $24 billion a year. Go read their 10k. Oh, yes - they rebate about $6.75 billion a year. You see, in the I&I market, rebates are the cost of entry. If you don't rebate, you don't sell. In the cancer world, end users simply use the best product because the best products are mandated by society and payer guidelines. You don't actually even need reps. Rev sells itself. Reps can't see docs anyway. You sound like the arrogant imbeciles that have blocked I&I from contracting all along. Had you just given 1.25% of R to sweeten the deals back in 2015, Otezla would have a 90% share in the pre-biologic market by now, but your arrogance killed it. Go have a beer with Scott, Jackie and Bob and you'll see.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Celgene
>
52-week low; not a good sign
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Celgene
>
52-week low; not a good sign
>